Gold Dust Missing from Pfizer Lab

$700,000 worth of gold dust has been reported missing from a Pfizer medical research lab in Missouri.

By | December 10, 2012

Flickr, Smitha MurthyIn the town of Chesterfield, Missouri, just outside of St. Louis, $700,000 worth of gold dust has gone missing from a drug discovery lab. After a routine inventory at a Pfizer medical research lab, which investigates biologics and other novel drugs, failed to locate the gold, the local police launched an investigation to determine whether or not it has been stolen.

“We’re not even sure if they just didn’t account for it and it was used naturally, or if it was stolen or misplaced,” Chesterfield Police Captain Steven Lewis told the St. Louis Post-Dispatch.

Experts estimate that the missing gold could weigh between 30 and 70 pounds, depending on purity. Though Pfizer declined to comment on how it uses the gold, such particles can be used in drug delivery and nanotechnology applications.

“We are taking this matter very seriously and working closely with local law enforcement authorities on this ongoing investigation,” Pfizer said in a statement, the Dispatch reported. “It would be inappropriate for us to comment any further at this time until the police investigation has been completed.”

Local gold dealers say it is unlikely that the gold dust will easily be sold, as jewelers tend to only buy from known dealers, and usually in very small quantities, Mike Matula, general manager of Missouri Gold Buyers in St. Louis, told the Dispatch. “If someone showed up with a bucket full of this stuff, no one would buy it over the counter, not from our store at least,” he said. “I imagine it would be pretty difficult to show up with 50 pounds of it without being noticed.”

(Hat tip to the Associated Press)

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Comments

Avatar of: Paul Stein

Paul Stein

Posts: 205

December 10, 2012

Woops.

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham